Robert Orlowski, Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared on X:
“Myeloma Paper of the Day:
Despite advances, AL amyloidosis pts experience substantial CV diagnoses & interventions in real‑world practice, particularly in pts w/ advanced disease stage (e.g. cumulative incidence in stage IIIa of 31.3% @ 36 mos).”
Title: Cardiovascular events and interventions in patients with light chain amyloidosis: a real-world study in the United States
Authors: Pedro A. Laires, Shona Fang, Jennifer Evans, Jeffrey Thompson, Abhishek Gaur, Brendon Staruk, Ankita Gupta, Richa Manwani.
You can read the full article on BMC Cardiovascular Disorders.

You can find other articles featuring Robert Orlowski on OncoDaily.